Physician

Shelli Hanks, MD

According to 2025 Medicare claims, Shelli Hanks, MD (NPI: 1225201395) practices radiation oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is ARIZONA UROLOGY SPECIALISTS, PLLC (NPI: 1740426485; TIN: 262944556) and primary practice location at 85704-7878. Hanks is affiliated with the Innovation Care Partners MSSP (ACO ID: A2029), participating under the MSSP model.

Hanks' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 234 traditional Medicare patients, billed 8,630 HCPCS/CPT codes, and received $1,482,004 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 211 prescription claims across 82 beneficiaries totaling $7,871 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 18 records totaling $415. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $911,244 and ending at $1,482,004. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,281 and ending at $7,871. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	324	4,787	$911,244
2016	343	6,064	$1,043,227
2017	358	7,346	$1,650,185
2018	314	6,443	$1,108,307
2019	273	7,109	$1,301,930
2020	225	8,672	$1,620,101
2021	186	4,640	$877,368
2022	245	9,074	$1,681,023
2023	224	7,065	$1,244,138
2024	234	8,630	$1,482,004

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	30	128	$4,281
2016	38	146	$2,829
2017	42	158	$3,480
2018	44	143	$1,907
2019	54	149	$3,291
2020	64	175	$3,345
2021	39	114	$4,551
2022	57	146	$1,746
2023	71	229	$3,929
2024	82	211	$7,871

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	102	3,106	$270
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	116	116	$125
77014	Ct guidance for insertion of radiation therapy fields	102	3,103	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	125	141	$54
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	218	265	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	200	10,825	$2,035

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$415	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shelli Hanks, MD?

Tedicare shows public-source Medicare data for Shelli Hanks, MD (NPI 1225201395), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shelli Hanks, MD have ACO affiliation data?

Shelli Hanks, MD is shown with ACO affiliation data for Innovation Care Partners MSSP (MSSP, ACO ID A2029).

What billing organization is linked to Shelli Hanks, MD?

Shelli Hanks, MD is linked to ARIZONA UROLOGY SPECIALISTS, PLLC (billing NPI 1740426485) in the available physician profile data.

Does Shelli Hanks, MD have Open Payments data?

Shelli Hanks, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.